📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Envisagenics

1.1 - Company Overview

Envisagenics Logo

Envisagenics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of AI/ML-driven RNA sequencing analysis solutions to accelerate therapeutic development. Offers SpliceCore, a platform that analyzes RNA splicing events to discover drug targets, and SpliceIO, a machine learning module that identifies RNA splicing-derived neoepitopes for immunotherapy, reducing biomedical data complexity.

Products and services

  • SpliceCore: AI/ML-driven platform leveraging RNA sequencing data to analyze RNA splicing events, discovering drug targets to accelerate therapeutic development
  • Computational-grade
  • SpliceIO: Machine-learning module focused on identifying RNA splicing-derived neoepitopes to guide immunotherapy development, supporting precise neoepitope detection from splicing alterations
  • Modular.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Envisagenics

Good Start Genetics Logo

Good Start Genetics

HQ: United States Website
  • Description: Provider of molecular genetic information for reproductive medicine, delivering clinically relevant and actionable insights on inherited genetic disorders to physicians and patients, enabled by a proprietary next-generation sequencing technology platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Good Start Genetics company profile →
Passage Bio Logo

Passage Bio

HQ: United States Website
  • Description: Provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Passage Bio company profile →
XyloCor Therapeutics Logo

XyloCor Therapeutics

HQ: United States Website
  • Description: Provider of gene therapies for coronary artery disease: XC001 treats refractory angina by stimulating new coronary blood vessel formation; XC002 is in development to regenerate cardiac tissue in heart failure after past heart attacks by converting non-functioning cardiac cells into functioning ones.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full XyloCor Therapeutics company profile →
Switchback Systems Logo

Switchback Systems

HQ: United States Website
  • Description: Provider of offerings aimed at democratizing DNA synthesis as an early-stage startup.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Switchback Systems company profile →
Megazyme Logo

Megazyme

HQ: Ireland Website
  • Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Megazyme company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Envisagenics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Envisagenics

2.2 - Growth funds investing in similar companies to Envisagenics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Envisagenics

4.2 - Public trading comparable groups for Envisagenics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Envisagenics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Envisagenics

What does Envisagenics do?

Envisagenics is a provider of AI/ML-driven RNA sequencing analysis solutions to accelerate therapeutic development. Offers SpliceCore, a platform that analyzes RNA splicing events to discover drug targets, and SpliceIO, a machine learning module that identifies RNA splicing-derived neoepitopes for immunotherapy, reducing biomedical data complexity.

Who are Envisagenics's competitors?

Envisagenics's competitors and similar companies include Good Start Genetics, Passage Bio, XyloCor Therapeutics, Switchback Systems, and Megazyme.

Where is Envisagenics headquartered?

Envisagenics is headquartered in United States.

How many employees does Envisagenics have?

Envisagenics has 1,000 employees 🔒.

When was Envisagenics founded?

Envisagenics was founded in 2010 🔒.

What sector and industry vertical is Envisagenics in?

Envisagenics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Envisagenics

Who are the top strategic acquirers in Envisagenics's sector and industry

Top strategic M&A buyers and acquirers in Envisagenics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Envisagenics?

Top strategic M&A buyers groups and sectors for Envisagenics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Envisagenics's sector and industry vertical

Which are the top PE firms investing in Envisagenics's sector and industry vertical?

Top PE firms investing in Envisagenics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Envisagenics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Envisagenics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Envisagenics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Envisagenics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Envisagenics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Envisagenics?

The key public trading comparables and valuation benchmarks for Envisagenics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Envisagenics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Envisagenics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Envisagenics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Envisagenics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Envisagenics's' sector and industry vertical?

Access recent funding rounds and capital raises in Envisagenics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Envisagenics